Immunohistochemical localization of interferon-γ in normal human ovary

References

• George F. W., Ojeda S. R. Vasoactive intestinal peptide enhances aromatase activity in the neonatal rat ovary before development of primary follicles or responsiveness to follicle-stimulating hormone. Proc. Natl. Acad. Sci. USA 1987; 84: 5803–7
   PubMed Web of Science ®Google Scholar
• Barad D. H., Ryan K. J., Elkind-Hirsch K., Makris A. Immunoreactive substance P in the human ovary. Am. J. Obstet. Gynecol. 1988; 159: 242–6
   PubMedGoogle Scholar
• Westergaard L. G., Yding Andersen C. Epidermal growth factor (EGF) in human preovulatory follicles. Hum. Reprod. 1989; 3: 257–60
   Google Scholar
• Eden J. A., Jones J., Carter G. D., Alaghband-Zadeh J. A comparison of follicular fluid levels of insulin-like growth factor-I in normal dominant and cohort follicles, polycystic and mul-ticystic ovaries. Clin. Endocrinol. 1988; 29: 327–36
   PubMed Web of Science ®Google Scholar
• Geisthoevel F., Moretti-Rojas I. M., Rojas F. J., Asch R. H. Immunoreactive insulin-like growth factor I in human follicular fluid. Hum. Reprod. 1989; 4: 35–8
   PubMedGoogle Scholar
• Khan S. A., Schmidt K., Hallin P., Di Pauli R., De Geyter C., Nieschlag E. Human testis cytosol and ovarian follicular fluid contain high amounts of interleukin-1-like factor(s). Mol. Cell. Endocrinol. 1988; 58: 221–30
   PubMed Web of Science ®Google Scholar
• Wang L. J., Norman R. J. Concentrations of immunoreactive interleukin-1 and inter-leukin-2 in human preovulatory follicular fluid. Hum. Reprod. 1992; 7: 147–50
   PubMed Web of Science ®Google Scholar
• Barak V., Yanai P., Treves A. J., Roisman I., Simon A., Laufer N. Interleukin-1: local production and modulation of human granulosa luteal cell steroidogenesis. Fertil. Steril. 1992; 58: 719–25
   PubMedGoogle Scholar
• Roby K. F., Weed J., Lyles R., Terranova P. F. Immunological evidence for a human ovarian tumor necrosis factor-α. J. Clin. Endocrinol. Metab. 1990; 71: 1096–102
   PubMedGoogle Scholar
• Zolti M., Meirom R., Shemesh M., Wallach D., Mashiach S., Shore Z., Ben Rafael Z. Granulosa cells as a source and target organ for TNFα. FEBS Lett. 1990; 261: 253–5
   PubMed Web of Science ®Google Scholar
• Grasso G., Muscettola M., Traina V., Causio F., Fanizza G., Cagnazzo G. Antiviral activity in follicular fluid of women undergoing in vitro fertilization and embryo transfer (IVF-ET). XIII Congresso Nazionale Società Italiana Fertilità Sterilità, Salsomaggiore TermeItaly, May 22–4, 1986; 1311–16
   Google Scholar
• Grasso G., Muscettola M., Traina V., Causio F., Fanizza G., Cagnazzo G. Presence of interferons in human follicular fluid after ovarian hyperstimulation for in vitro fertilization. Med. Sci. Res. 1988; 16: 167–8
   Google Scholar
• De Maeyer E., De Maeyer-Guignard J. Interferons. The Cytokine Handbook, A. W. Thomson. Academic Press, London 1991; 213–39
   Google Scholar
• Grasso G., Muscettola M. Possible role of interferon-gamma in ovarian function. Ann. NY Acad. Sci. 1992; 650: 191–6
   PubMedGoogle Scholar
• Hsu S. -M., Raine L., Fanger H. Use of avidin—biotin—peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• Kaneko F., Ando M., Takahashi Y., Ohkawara A., Minagawa T. Immune complexes and delayed type hypersensitivity reactions in psoriasis. Proc. Jpn. Soc. Invest. Dermatol. 1988; 12: 74–5
   Google Scholar
• Satoh Y. -I., Kasama K., Kajita A., Shimizu H., Ida N. Different pharmacokinetics between natural and recombinant human inter-feron beta in rabbits. J. Interferon Res. 1984; 4: 411–22
   PubMedGoogle Scholar
• Hill J. A., Barbieri R. L., Anderson D. J. Detection of T8 (suppressor/cytotoxic) lymphocytes in human ovarian follicular fluid. Fertil. Steril. 1987; 47: 114–17
   PubMedGoogle Scholar
• McNatty K. P., Hunter W. M., McNeilly A. S., Sawers R. S. Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human Graafian follicles throughout the menstrual cycle. J. Endocrinol. 1975; 64: 555–71
   PubMed Web of Science ®Google Scholar
• McNatty K. P., Baird D. T., Bolton A., Chambers P., Corker C. S., McLean H. Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. J. Endocrinol. 1976; 71: 77–85
   PubMed Web of Science ®Google Scholar
• Chikazawa K., Araki S., Tamada T. Morphological and endocrinological studies on follicular development during the human menstrual cycle. J. Clin. Endocrinol. Metab. 1986; 62: 305–13
   PubMedGoogle Scholar
• Zelezmk A. J., Schuler H. M., Reichert L. E., Jr. Gonadotropin binding sites in the rhesus monkey ovary. Role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 1981; 109: 356–62
   PubMedGoogle Scholar
• Cohen J. H. M., Danel L., Cordier G., Saez S., Revillard J. -P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OK T8-positive cells. J. Immunol. 1983; 131: 2767–71
   PubMed Web of Science ®Google Scholar
• Stimson W. H. Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand. J. Immunol. 1988; 28: 345–50
   PubMedGoogle Scholar
• Grasso G., Muscettola M. The influence of beta-estradiol and progesterone on interferon gamma production in vitro. Int. J. Neurosci. 1990; 51: 315–17
   Google Scholar
• Yousefi S., Karamlou K., Vaziri N., Carandang G., Ocaritz J., Cesano T. The effect of gonadotropins on the production of human interferon-γ by mononuclear cells. J. Interferon Res. 1993; 13: 213–20
   PubMedGoogle Scholar
• Parr E. L. Histological examination of the rat ovarian follicle wall prior to ovulation. Biol. Reprod. 1974; 11: 483–503
   PubMedGoogle Scholar
• Cavender J. L., Murdoch W. J. Morphological studies on the microcirculatory system of periovulatory ovine follicles. Biol. Reprod. 1988; 39: 989–97
   PubMed Web of Science ®Google Scholar
• Yu C. -L., Haskard D. O., Cavender D., Johnson A. R., Ziff M. Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin. Exp. Immunol. 1985; 62: 554–60
   PubMed Web of Science ®Google Scholar
• Duijvestijn A. M., Schreiber A. B., Butcher E. C. Interferon-γ regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc. Natl. Acad. Sci. USA 1986; 83: 9914–18
   Google Scholar
• Gorospe W. C., Tuchel T., Kasson B. G. γ-Interferon inhibits rat granulosa cell differentiation in culture. Biochem. Biophys. Res. Comm. 1988; 157: 891–7
   PubMed Web of Science ®Google Scholar
• Fukuoka M., Yasuda K., Fujiwara H., Iwai M., Kanzaki H., Mori T. Interactions between interferon γ, tumour necrosis factor α, and interleukin-1 in modulating progesterone and oestradiol production by human luteinized granulosa cells in culture. Hum. Reprod. 1992; 7: 1361–4
   PubMed Web of Science ®Google Scholar
• Wang H. Z., Lu S. H., Han X. J., Zhou W., Sheng W. X., Sun Z. D., Gong Y. T. Inhibitory effect of interferon and tumour necrosis factor on human luteal function in vitro. Fertil. Steril. 1992; 58: 941–5
   PubMedGoogle Scholar
• Hill J. A., Welch W. R., Fans H. M. P., Anderson D. J. Induction of class II major histocompatibility complex antigen expression in human granulosa cells by interferon gamma: a potential mechanism contributing to autoimmune ovarian failure. Am. J. Obstet. Gynecol. 1990; 162: 534–40
   PubMed Web of Science ®Google Scholar
• Arenzana-Seisdedos F., Virelizier J. L., Fiers W. Interferons as macrophage-activating factors. 3. Preferential effects of interferon-γ on the interleukin 1 secretory potential of fresh or aged human monocytes. J. Immunol. 1985; 134: 2444–8
   PubMed Web of Science ®Google Scholar
• Scuderi P., Sterling K. E., Raitano A. B., Gro-gan T. M., Rippe R. A. Recombinant interferon-γ stimulates the production of human tumor necrosis factor in vitro. J. Interferon Res. 1987; 7: 155–64
   PubMedGoogle Scholar
• Petraglia F., Sacerdote P., Cossarizza A., Angioni S., Genazzani D., Franceschi C., Muscettola M., Grasso G. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-γ production. J. Clin. En-docrinol. Metab. 1991; 72: 496–502
   PubMedGoogle Scholar
• Johnson H. M., Torres B. A. Peptide growth factors PDGF, EGF, and FGF regulate interferon-y production. J. Immunol. 1985; 134: 2824–6
   PubMedGoogle Scholar
• Muscettola M., Grasso G. Somato-statin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology 1990; 180: 419–30
   PubMed Web of Science ®Google Scholar
• Muscettola M., Grasso G. Neuropep-ride modulation of interferon-gamma production. Int. J. Neurosci. 1990; 51: 189–91
   PubMed Web of Science ®Google Scholar
• Schultz R. M. Interleukin 1 and interferon-γ: cytokines that provide reciprocal regulation of macrophage and T cell function. Toxicol. Pathol. 1987; 15: 333–7
   PubMedGoogle Scholar
• Kasahara T., Hooks J. J., Dougherty S. F., Oppenheim J. J. Interleukin 2 (IL2)-mediated immune interferon (IFN-γ) production by human T cells and T cell subsets. J. Immunol. 1983; 130: 1784–9
   PubMed Web of Science ®Google Scholar
• Perlstein K. T., Palladino M. A., Welte K., Vilcek J. Purified human interleukin 2 enhances induction of immune interferon. Cell. Immunol 1983; 80: 1–9
   PubMedGoogle Scholar